leadf
logo-loader

NA Proactive news snapshot: Mandalay Resources, OTC Markets Group, Cardiol Therapeutics, Naturally Splendid, Nano One Materials UPDATE ...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Newspapers and laptop
Your daily round-up from the world of Proactive

OTC Markets Group Inc (OTCQX:OTCM) will report its first quarter financial results after market close on May 13, the group told shareholders Wednesday. It will also hold a conference call and webcast the following day to discuss the results in further detail. The call is accessible by phone at 1-877-665-5564 (Domestic); 1-470-495-9522 (International); Pin: 6045317 and via webcast at https://edge.media-server.com/mmc/p/8s2omsm9.

TRACON Pharmaceuticals Inc (NASDAQ:TCON) announced that it will report its first quarter 2020 financial and operating results after the close on May 13. In addition, management will host a conference call on May 13 at 4:30 pm Eastern Time to provide discuss the financial results. Domestic investors can dial up (855) 779-9066, while international investors can call  (631) 485-4859 using the passcode 6453397. They can also visit www.traconpharma.com and go to the events section within the company’s investor section. A replay of the webcast will be available for 60 days on the site.

Mandalay Resources Corporation (TSE:MND) (OTCQB:MNDJF) says that due to the public health impact of the coronavirus (COVID-19) pandemic, the venue of its Annual General and Special Meeting have been changed. The AGM will still proceed on May 20 at 9 am (Toronto time) but will now be held at the Fairmont Royal York Hotel in Toronto. All other details of the AGM, including the resolutions to be proposed at the meeting, remain unchanged. Also the company is discouraging physical attendance in person. The AGM will not be open to the general public and will be limited to registered shareholders and duly appointed proxyholders only. Shareholders may listen by live audio teleconference by dialing 877-407-8289 or 201-689-8341. Shareholders will not be entitled to vote at, or otherwise participate in, by way of teleconference or other electronic means. 

Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) has filed a new patent application to cover the use of cannabidiol in patients with COVID-19, the disease caused by coronavirus. Cannabidiol, or CBD, could reduce the severity and prevent the progression of COVID-19 symptoms in patients with pre-existing cardiovascular conditions, according to Cardiol. The Oakville-based company is developing CBD-based therapies for heart disease as well as proprietary nanotechnology to deliver pharmaceutical cannabidiol directly into sites of inflammation in the heart.

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCMKTS:NSPDF), the healthy foods manufacturer, has struck a sales deal with Vancouver-based Ecotrend Ecologics to market some of its brands across Canada, sending shares higher. It has established a number of brands such as Natera Sport, Natera Hemp Foods, CHII, Elevate Me and Woods Wild Bar. The first product that Ecotrend will market and distribute for the firm is the Natera Sport Procurc 30, curcumin-based supplements. Curcumin is a natural ingredient that is traditionally used for its anti-fungal, anti-bacterial and anti-viral properties.

Nano One Materials Corp (CVE:NNO) (OTCPINK:NNOMF) said the Province of British Columbia is contributing around $3.03 million to its ‘Scaling of Advanced Battery Materials Project’ in addition to a previously announced $5.25 million contribution from Sustainable Development Technology Canada (SDTC). The contribution from the Province is being made as part of a funding partnership with SDTC and augments Nano One's existing project funding agreement with SDTC, executed in September 2019, bringing the total contribution to $8.28 million. Nano One said the original project scope and milestone deliverables remain unchanged.

IEC Electronics Corp (NASDAQ:IEC) posted fiscal second-quarter results on Wednesday that saw its revenue jump 18.4% year-over-year on the back of bookings from an increasingly expanded and diverse customer base. For its fiscal second quarter ended March 27, 2020, the Newark, New York-based provider of electronic manufacturing services to advanced technology companies, reported revenue of $44.2 million, compared to $37.3 million in the fiscal second quarter of 2019. Gross profit for its second quarter was $5.5 million, or 12.5% of sales, compared to gross profit of $4.6 million, or 12.3% of sales in the fiscal second quarter of 2019. The company lowered its selling and admin expenses to $3.2 million in the quarter, compared to $3.3 million in the same quarter a year earlier.

Humanigen Inc (OTCQB:HGEN) announced Wednesday that the first coronavirus (COVID-19) patient has been dosed in a Phase 3 trial of its drug lenzilumab. Lenzilumab is a proprietary anti-human granulocyte macrophage-colony stimulating factor (GM-CSF), which the company believes can potentially prevent serious outcomes in hospitalized patients with COVID-19 pneumonia. The now ongoing trial is the first randomized, double-blind, placebo-controlled, multi-center, Phase 3 study of an anti-GM-CSF conducted in the US, the company said.

Information Services Corp (TSE:ISV), which provides registry services for public records, continues to grow the business and has posted what it called "excellent" first quarter results despite the economic global circumstances. The three months to March 31, 2020, saw another rise in net income, revenue and margins compared to the same period a year earlier, the company revealed. Net income came in at C$3.5 million versus a figure of C$3 million in 2019, on revenue of C$29.6 million, up 3.5% from C$28.6 million seen a year ago. EBITDA (earnings before interest, taxes, depreciation and amortization) for the three months was C$7.8 million, up from C$7.4 million in the first quarter of 2019. Information Services Corp also confirmed it will pay a quarterly dividend of C$0.20 a share on or before July 15 this year to shareholders of record as at June 30.

CytoDyn Inc (OTCQB:CYDY) has shared a pre-print online version of a manuscript that describes the immunological mechanism through which its flagship drug leronlimab restores immune homeostasis, or balance by reducing “viral load,” and reverses “hyper immune activation” and “inflammation” in critically ill coronavirus (COVID-19) patients. In its effort to aid the US battle against COVID-19, Vancouver, Washington- based CytoDyn said it has posted the manuscript on Research Square and MedRxiv detailing the immunological pathway by which leronlimab restores immune function and impacts coronavirus patients positively. The manuscript has been submitted for publication and is currently under peer review, the company said. A copy of the pre-print manuscript has also been shared with the World Health Organization.

GR Silver Mining Ltd (CVE:GRSL) (OTCQB:GLYXF) said recent exploration at its San Marcial project in Mexico has underscored the potential for the resource to be expanded there. The project, which has potential to become an open-pit mine, already boasts a resource, published in 2019, of 36 million ounces of silver equivalent in the higher confidence indicated category and 11 million ounces in inferred. "The company is focused on increasing the resource inventory at San Marcial. Extension of the underground tunnel for drill access is advanced, which will allow the company to drill test the down-dip extensions to the NI 43-101 resource later this year," GR Silver chief executive Marcio Fonseca said Wednesday in a statement.

Capstone Turbine Corporation (NASDAQ:CPST), the maker of clean-energy microturbines, announced Wednesday it has received an order to help modernize a water pollution facility (WPF) in upstate New York. The company said the order is for a three-bay, 400-kilowatt (kw), C400 Signature Series (C400S) microturbine-based energy system that will utilize a combined heat and power (CHP) application and will run on biogas produced on-site from municipal solid waste. Capstone noted that a recent study by the US Energy Information Administration said renewables will be the fastest-growing source of electricity generation through 2050 because of continuing declines in capital costs and the introduction of higher state-level renewable energy targets. 

Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) said it has received ethics approval from the Royal Brisbane & Women’s Hospital’s Human Research Ethics Committee for the planned Phase 2 Idiopathic Pulmonary Fibrosis (IPF) and chronic cough clinical study of its re-purposed drug NP-120 (Ifenprodil), an NMDA receptor antagonist. The two sites covered under the ethics approval are Cairns Hospital in Queensland and Concord Repatriation General Hospital in New South Wales. The company is awaiting ethics approval from one additional site in Australia and two sites from New Zealand that are participating in the study. Enrollment in the Ifenprodil Phase 2 IPF and chronic cough clinical trial is expected to begin in late June 2020.

Ideanomics Inc (NASDAQ:IDEX) said its Mobile Energy Global (MEG) division has finalized its electric vehicle and energy business units under its sales-to-financing-to-charging model (S2F2C).  Each business unit has been developed to focus on a key area of revenue, the company said Wednesday in a statement. It is part of the company's plans to onboard diversified revenue streams as it scales in Asia and beyond, having its own team and revenue objectives to provide focus and accountability for the MEG division, Ideanomics added.

Nano One Materials Corp (CVE:NNO) (OTCPINK:NNOMF) said the Province of British Columbia is contributing around $3.03 million to its ‘Scaling of Advanced Battery Materials Project’ in addition to a previously announced $5.25 million contribution from Sustainable Development Technology Canada (SDTC). The contribution from the Province is being made as part of a funding partnership with SDTC and augments Nano One's existing project funding agreement with SDTC, executed in September 2019, bringing the total contribution to $8.28 million. Nano One said the original project scope and milestone deliverables remain unchanged.

IEC Electronics Corp (NASDAQ:IEC) posted fiscal second-quarter results on Wednesday that saw its revenue jump 18.4% year-over-year on the back of bookings from an increasingly expanded and diverse customer base. For its fiscal second quarter ended March 27, 2020, the Newark, New York-based provider of electronic manufacturing services to advanced technology companies, reported revenue of $44.2 million, compared to $37.3 million in the fiscal second quarter of 2019. Gross profit for its second quarter was $5.5 million, or 12.5% of sales, compared to gross profit of $4.6 million, or 12.3% of sales in the fiscal second quarter of 2019. The company lowered its selling and admin expenses to $3.2 million in the quarter, compared to $3.3 million in the same quarter a year earlier.

Vendetta Mining Corp (CVE:VTT) (OTCMKTS:VDTAF) said Wednesday that it had closed the first tranche of a previously announced fundraising and has put in a request to upsize the financing to the Toronto Venture Exchange. The request is to increase the private placement, announced in February this year, of up to 11 million units to 20 million units to raise gross proceeds of C$800,000. The mining firm has closed the first tranche with over 13.9 million units issued at C$0.04 a throw for gross proceeds of C$558,482. The group said net proceeds will be used to advance the development of the group's wholly-owned owned Pegmont lead-zinc project in Queensland, Australia and for general working capital.

Antibe Therapeutics Inc (CVE:ATE) (OTCQB:ATBPF) has named Dr Joseph Stauffer, an industry veteran who has worked for both the US government and the private sector, to the new role of chief medical officer (CMO). An anesthesiologist, Dr Stauffer has served as CMO in public and private drug therapy companies for nearly 20 years, building teams of physicians, scientists, regulators and safety experts to drive clinical success for a number of chronic and acute pain assets.  Antibe said he will assume a leadership role in its clinical development strategy and its increasing engagement with global regulatory agencies and potential large-market partners.

GSRX Industries Inc (OTCQB:GSRX) said Wednesday that it has added two experienced business development executives, Troy Dooly and Shaun Dale to the company’s board to create long-tern value for the organization. Dooly has over 37 years of experience in operations and business development in various industries. He has not only been a chief operating officer and chief commercial officer but founded multiple marketing and distribution companies. In addition, Dooly is a public speaker and radio host. Dale, on the other hand, brings 25 years of operational management experience to the company.  

Champignon Brands Inc (CSE:SHRM) (OTCBQ:SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, said it has appointed Pat McCutcheon to its board of directors effective immediately. McCutcheon is currently the chief executive of MediPharm Labs Corp (TSX:LABS), a global cannabis company he initially founded after identifying an important, overlooked segment of the burgeoning cannabis market to create the first pure-play cannabis company focused solely on extraction and API manufacturing.

Power Ore Inc (CVE:PORE) said it has received a six-month extension on all of its remaining milestone obligations on the Opemiska Copper Complex acquisition. Opemiska, a large copper project surrounded by infrastructure in Quebec, was acquired in December 2018. The deferral comes as a result of the ongoing coronavirus (COVID-19) pandemic, which has forced the closure or stoppage of non-essential work in the province of Quebec. Power Ore told shareholders that it has already completed its work commitments up until May 22, 2022. The extension allows the Toronto-based explorer to defer its $150,000 payment to Ex-In until May 22, 2021.

American Battery Metals Corporation (OTCQB:ABML) updated investors Wednesday on a pair of financing initiatives affected by the coronavirus pandemic and said it plans to move forward with the development of its battery metals recycling plant. In February, the company signed an agreement with Unifinance Limited to sell Series B preferred shares at a fixed price of $0.25 per share. American Battery Metals said it has yet to receive any funds, which Unifinance has attributed to the pandemic, but the firm has committed to making the full investment by June 1. Separately, the company underwent a private placement offering of more than $1 million of common stock and warrants which included insiders and friends and family of the company. Since March 27, the company has received additional subscriptions worth $475,000. The board of directors has extended the offering through to May 31, the company said.

Silver Range Resources Ltd (CVE:SNG) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 412,839 shares in consideration of certain geological and consulting services totalling $35,437.50, provided to the company between October 1, 2019, and March 31, 2020, under an agreement dated April 1, 2019.

Codebase Ventures Inc. (CSE:CODE) (OTCQB:BKLLF) announced that it has completed the second closing of a non-brokered private placement. The company said it issued 20,470,000 units at a price of $0.002 per unit, for gross proceeds of $409,400. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.05 for a period of two years from the date of closing. Securities issued pursuant to this financing are subject to trading restrictions until September 5, 2020. Codebase paid finders fees to a qualified finder of $13,072 and issued 653,600 broker warrants, which are on the same terms as the warrants forming part of the units. It said net proceeds from the private placement will be used for general working capital and to fund future investments.

Arcadia Biosciences, Inc. (NASADAQ:RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, has announced that it will release its financial and business results for the first quarter of 2020 after market close on May 13, 2020. The company said it has scheduled a conference call for 4.30pm Eastern time (1.30pm Pacific time) to discuss the results and the year's key strategic achievements. Interested participants can join the conference call using the following numbers: US Toll-Free Dial-In +1-844-243-4690; International Dial-In +1-225-283-0138; Passcode: 3560919 A live webcast of the conference call will be available on the Investors section of Arcadia's website and following completion of the call, a recorded replay will also be available there too. www.arcadiabio.com

WeedMD Inc. (CVE:WMD) (OTCQX:WDDMF), a federally-licensed producer and distributor of medical-grade cannabis, has announced that Angelo Tsebelis, its chief executive officer and Stephen Ng, its chief commercial officer, will be presenting in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference on Tuesday, May 12, 2020, at 8.40am Eastern Time. The conference will be held via webcast and a presentation link will be provided on WeedMD’s Investor Events page closer to the date. Canaccord Genuity’s Annual Global Cannabis Conference is an investor-focused virtual event that engages a global network of leading players in the cannabis industry. For more information regarding the conference and to schedule a one-on-one meeting with WeedMD, please contact KCSA Strategic Communications at weedmd@kcsa.com or Canaccord Genuity directly.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Humanigen, Inc. named herein, including the promotion by the Company of Humanigen, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

FenixOro Gold continues aggressive drill program at their Abriaqui Project...

FenixOro Gold (CSE: FENX-OTCQB: FDVXF) CEO John Carlesso joined Steve Darling from Proactive to bring details about their drilling program that is ongoing at their gold silver and copper project in Colombia. That project is called Abriaqui and sits along a very mineralized belt. Carlesso...

2 hours, 58 minutes ago

14 min read